{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:20:06Z","timestamp":1793384406501,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.canrad.2020.02.007","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T17:58:05Z","timestamp":1590083885000},"page":"388-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Benefits of positron emission tomography scans for the evaluation of radiotherapy"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5323-9910","authenticated-orcid":false,"given":"P.","family":"Decazes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Thureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Modzelewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Damilleville-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2020.02.007_bib0430","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.canrad.2011.07.227","article-title":"Interest of FDG-PET for lung cancer radiotherapy","volume":"15","author":"Thureau","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2020.02.007_bib0435","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using (18F)-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2020.02.007_bib0440","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1067\/j.cpradiol.2008.01.001","article-title":"Positron emission tomography\/computed tomography potential pitfalls and artifacts","volume":"38","author":"Wang","year":"2009","journal-title":"Curr Probl Diagn Radiol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0445","first-page":"152","article-title":"How to use PET\/CT in the evaluation of response to radiotherapy","volume":"62","author":"Decazes","year":"2017","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0450","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00259-014-2687-9","article-title":"FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)","volume":"41","author":"Vera","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0455","first-page":"648","article-title":"Therapy response assessment in radiotherapy of lung cancer","volume":"55","author":"Van Elmpt","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0460","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.2013.53.1228","article-title":"Recent clinical advances in lung cancer management","volume":"32","author":"Johnson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0465","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0470","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.radonc.2011.07.023","article-title":"Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC)","volume":"102","author":"Edet-Sanson","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0475","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00259-017-3762-9","article-title":"Role of interim (18F)-FDG-PET\/CT for the early prediction of clinical outcomes of non-small cell lung cancer (NSCLC) during radiotherapy or chemoradiotherapy. A systematic review","volume":"44","author":"Cremonesi","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0480","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.prro.2015.10.009","article-title":"Adaptive planning using positron emission tomography for locally advanced lung cancer: a feasibility study","volume":"6","author":"Kelsey","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0485","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2018.10.006","article-title":"Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer","volume":"132","author":"Kong F-MS","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0490","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13014-018-1163-2","article-title":"Delineation of lung cancer with FDG PET\/CT during radiation therapy","volume":"13","author":"Ganem","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0495","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.radonc.2010.10.011","volume":"98","author":"Vera","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0500","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2967\/jnumed.116.188367","article-title":"Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by F-misonidazole PET\/CT in patients with non-small cell lung carcinoma (RTEP5 study)","volume":"58","author":"Vera","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0505","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00259-019-04285-9","article-title":"Radiotherapy boost in patients with hypoxic lesions identified by (18F)-Fmiso PET\/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity?","volume":"46","author":"Vera","year":"2019","journal-title":"Eur J Nuclear Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0510","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0515","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Lordick","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0520","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ijsu.2014.04.014","article-title":"Complete pathological response after neoadjuvant treatment in locally advanced esophageal cancer predicts long term survival: a retrospective cohort study","volume":"12","author":"Rizvi","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.canrad.2020.02.007_bib0525","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2967\/jnumed.110.079566","article-title":"Early repeated (18F)-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus","volume":"51","author":"Malik","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0530","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00259-013-2450-7","article-title":"The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)","volume":"40","author":"Palie","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0535","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s00259-015-3004-y","article-title":"High FDG uptake areas on preradiotherapy PET\/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer","volume":"42","author":"Calais","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0540","first-page":"1118","article-title":"The predictive value of (18F)-FDG PET for pathological response of primary tumor in patients with esophageal cancer during or after neoadjuvant chemoradiotherapy: a meta-analysis","volume":"46","author":"Cong","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0545","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MNM.0b013e3283334e2b","article-title":"Can (18F)-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients?","volume":"31","author":"Farrag","year":"2010","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.canrad.2020.02.007_bib0550","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00259-011-1759-3","article-title":"Early FDG PET at 10 or 20Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer","volume":"38","author":"Hentschel","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0555","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ijrobp.2010.07.019","article-title":"Can (18F)-FDG-PET during radiotherapy replace post-therapy scanning for detection\/demonstration of tumor response in head-and-neck cancer?","volume":"81","author":"Ceulemans","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.02.007_bib0560","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2012.03.001","article-title":"Can \u201cearly\u201d and \u201clate\u201d (18F)-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radiochemotherapy?","volume":"103","author":"Castaldi","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0565","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijrobp.2017.02.217","article-title":"Interim (18F)-FDG PET\/CT during chemoradiation therapy in the management of head and neck cancer patients: a systematic review","volume":"98","author":"Garibaldi","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.02.007_bib0570","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2015.09.015","article-title":"Serial (18F)-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome","volume":"117","author":"Wiedenmann","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0575","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00259-014-2730-x","article-title":"A prospective clinical study of (18F)-Faza PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy","volume":"41","author":"Servagi-Vernat","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0580","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2967\/jnumed.109.069310","article-title":"(18F)-FLT PET\/CT for early response monitoring and dose escalation in oropharyngeal tumors","volume":"51","author":"Troost","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0585","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12149-013-0694-8","article-title":"Changes in (18F)-fluorothymidine and (18F)-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy","volume":"27","author":"Hoshikawa","year":"2013","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0590","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0595","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0600","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.radonc.2014.11.026","article-title":"The role of diffusion-weighted MRI and (18F)-FDG PET\/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review","volume":"113","author":"Joye","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0605","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0610","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1245\/s10434-014-3753-z","article-title":"Systematic review of FDG-PET prediction of complete pathological response and survival in rectal cancer","volume":"21","author":"Memon","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0615","unstructured":"NCCN \u2013 Evidence-Based Cancer Guidelines, oncology drug compendium, oncology continuing medical education. [Accessed 25 August2019. Available at: https:\/\/www.nccn.org\/]"},{"key":"10.1016\/j.canrad.2020.02.007_bib0620","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.athoracsur.2004.04.046","article-title":"Utility of PET, CT and EUS to identify pathologic responders in esophageal cancer","volume":"78","author":"Swisher","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.canrad.2020.02.007_bib0625","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/SLA.0b013e3181a38e9e","article-title":"Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer","volume":"249","author":"Sarkaria","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2020.02.007_bib0630","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s11605-014-2488-2","article-title":"A systematic review of the predictive value of (18F)-FDG-PET in esophageal and esophagogastric junction cancer after neoadjuvant chemoradiation on the survival outcome stratification","volume":"18","author":"Schollaert","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.canrad.2020.02.007_bib0635","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/SLA.0000000000001902","article-title":"Can CT-PET and endoscopic assessment post-neoadjuvant chemoradiotherapy predict residual disease in esophageal cancer?","volume":"264","author":"Heneghan","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2020.02.007_bib0640","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jtho.2019.04.004","article-title":"Detecting pathological complete response in esophageal cancer after neoadjuvant therapy based on imaging techniques: a diagnostic systematic review and meta-analysis","volume":"14","author":"de Gouw","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0645","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/SLA.0b013e31828676c4","article-title":"Ineffectiveness of (18F)-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer","volume":"258","author":"Piessen","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2020.02.007_bib0650","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/RLU.0000000000001269","article-title":"PET\/CT response criteria (European Organization for Research and Treatment of Cancer) predict survival better than response evaluation criteria in solid tumors in locally advanced cervical cancer treated with chemoradiation","volume":"41","author":"Yoon","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0655","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/hed.1136","article-title":"Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer","volume":"23","author":"Greven","year":"2001","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2020.02.007_bib0660","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijrobp.2008.07.019","article-title":"Clinical significance of postradiotherapy (18F)-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report","volume":"74","author":"Yao","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.02.007_bib0665","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/GCO.0b013e32835a7e96","article-title":"FDG PET\/CT in monitoring response to treatment in gynecological malignancies","volume":"25","author":"Amit","year":"2013","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0670","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1200\/JCO.2012.47.5947","article-title":"Prediction of survival by (18F)-fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668\/RTOG 0235 trial","volume":"31","author":"Machtay","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0675","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ijrobp.2015.04.026","article-title":"Regional lymph node uptake of (18F)-fluorodeoxyglucose after definitive chemoradiation therapy predicts local-regional failure of locally advanced non-small cell lung cancer: results of ACRIN 6668\/RTOG 0235","volume":"93","author":"Markovina","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.02.007_bib0680","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/JTO.0000000000000185","article-title":"Primary tumor standardized uptake value measured on (18F)-fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis","volume":"9","author":"Na","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0685","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1148\/rg.244035160","article-title":"Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis","volume":"24","author":"Choi","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.canrad.2020.02.007_bib0690","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1148\/rg.313105096","article-title":"Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer","volume":"31","author":"Larici","year":"2011","journal-title":"RadioGraphics"},{"key":"10.1016\/j.canrad.2020.02.007_bib0695","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1470-2045(09)70353-5","article-title":"PET-CT for response assessment and treatment adaptation in head and neck cancer","volume":"11","author":"Bussink","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0700","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(08)60728-X","article-title":"Head and neck cancer","volume":"371","author":"Argiris","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2020.02.007_bib0705","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00259-011-1893-y","article-title":"Diagnostic performance of post-treatment FDG PET or FDG PET\/CT imaging in head and neck cancer: a systematic review and meta-analysis","volume":"38","author":"Gupta","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0710","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT surveillance versus neck dissection in advanced head and neck cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0715","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1200\/JCO.2017.73.5845","article-title":"Fluorodeoxyglucose-positron emission tomography\/computed tomography after concurrent chemoradiotherapy in locally advanced head-and-neck squamous cell cancer: the ECLYPS study","volume":"35","author":"Van den Wyngaert","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0720","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1017\/S0022215116000396","article-title":"Imaging in head and neck cancer: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"Lewis-Jones","year":"2016","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0725","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1001\/jama.298.19.2289","article-title":"Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma","volume":"298","author":"Schwarz","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2020.02.007_bib0730","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijrobp.2011.05.053","article-title":"Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer","volume":"83","author":"Schwarz","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2020.02.007_bib0735","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/JGO.2016.003954","article-title":"Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline","volume":"2","author":"Chuang","year":"2016","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0740","first-page":"45","article-title":"Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-(18F)-fluoro-D-glucose positron emission tomography\/computed tomography","volume":"7","author":"Sawada","year":"2016","journal-title":"Lung Cancer (Auckl)"},{"key":"10.1016\/j.canrad.2020.02.007_bib0745","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1634\/theoncologist.2013-0068","article-title":"Early detection of recurrent disease by FDG-PET\/CT leads to management changes in patients with squamous cell cancer of the head and neck","volume":"18","author":"Kostakoglu","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.canrad.2020.02.007_bib0750","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0284185113498536","article-title":"Diagnostic efficacy of PET and PET\/CT for recurrent lung cancer: a meta-analysis","volume":"55","author":"He","year":"2014","journal-title":"Acta Radiol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0755","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2214\/AJR.16.16532","article-title":"The value of FDG PET\/CT in treatment response assessment, follow-up, and surveillance of lung cancer","volume":"208","author":"Sheikhbahaei","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0760","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jamaoncol.2017.0973","article-title":"Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques","volume":"3","author":"Leeman","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0765","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2214\/AJR.14.14166","article-title":"Diagnostic accuracy of follow-up FDG PET or PET\/CT in patients with head and neck cancer after definitive treatment: a systematic review and meta-analysis","volume":"205","author":"Sheikhbahaei","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0770","doi-asserted-by":"crossref","first-page":"v184","DOI":"10.1093\/annonc\/mdq185","article-title":"Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Gr\u00e9goire","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0775","doi-asserted-by":"crossref","first-page":"S1292","DOI":"10.1245\/s10434-015-4840-5","article-title":"Prognosis and treatment after diagnosis of recurrent esophageal carcinoma following esophagectomy with curative intent","volume":"22","author":"Parry","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0780","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2967\/jnumed.115.155580","article-title":"Diagnostic performance of (18F)-FDG PET and PET\/CT for the detection of recurrent esophageal cancer after treatment with curative intent: a systematic review and meta-analysis","volume":"56","author":"Goense","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17120","article-title":"Positron emission tomography\/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling","volume":"17","author":"Meads","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.canrad.2020.02.007_bib0790","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MNM.0000000000000026","article-title":"Diagnostic value of (18F)-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis","volume":"35","author":"Chu","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.canrad.2020.02.007_bib0795","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/1471-0528.12488","article-title":"Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation","volume":"121","author":"Meads","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.canrad.2020.02.007_bib0800","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00404-014-3263-z","article-title":"Diagnosis of recurrent uterine cervical cancer: PET versus PET\/CT: a systematic review and meta-analysis","volume":"290","author":"Ding","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.canrad.2020.02.007_bib0805","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5114\/aoms.2014.42572","article-title":"Positron emission tomography alone, positron emission tomography-computed tomography and computed tomography in diagnosing recurrent cervical carcinoma: a systematic review and meta-analysis","volume":"10","author":"Xiao","year":"2014","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.canrad.2020.02.007_bib0810","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/1471-0528.12460","article-title":"Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis","volume":"121","author":"Auguste","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.canrad.2020.02.007_bib0815","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2017.03.022","article-title":"An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations","volume":"146","author":"Salani","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2020.02.007_bib0820","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.semnuclmed.2016.07.004","article-title":"Is there use for FDG-PET in prostate cancer?","volume":"46","author":"Jadvar","year":"2016","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0825","doi-asserted-by":"crossref","first-page":"18","DOI":"10.18383\/j.tom.2015.00130","article-title":"Positron emission tomography in prostate cancer: summary of systematic reviews and meta-analysis","volume":"1","author":"Jadvar","year":"2015","journal-title":"Tomography"},{"key":"10.1016\/j.canrad.2020.02.007_bib0830","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RLU.0b013e3182867f3c","article-title":"Choline PET or PET\/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis","volume":"38","author":"Evangelista","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0835","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1515\/cclm-2013-0675","article-title":"Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET\/CT in restaging prostate cancer patients: a meta-analysis","volume":"52","author":"Treglia","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.canrad.2020.02.007_bib0840","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00259-016-3329-1","article-title":"(18F)-FACBC (anti1-amino-3-(18F)-fluorocyclobutane-1-carboxylic acid) versus (11C)-choline PET\/CT in prostate cancer relapse: results of a prospective trial","volume":"43","author":"Nanni","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0845","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00259-017-3711-7","article-title":"Diagnostic performance of (68Ga)-PSMA-11 (HBED-CC) PET\/CT in patients with recurrent prostate cancer: evaluation in 1007 patients","volume":"44","author":"Afshar-Oromieh","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2020.02.007_bib0850","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S1470-2045(19)30415-2","article-title":"(18F)-fluciclovine PET-CT and (68Ga)-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial","volume":"20","author":"Calais","year":"2019","journal-title":"Lancet Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820300706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820300706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:33:01Z","timestamp":1761136381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321820300706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1278321820300706"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2020.02.007","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefits of positron emission tomography scans for the evaluation of radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2020.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}